Wells Fargo & Company Fibrogen Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Fibrogen Inc stock. As of the latest transaction made, Wells Fargo & Company holds 10,000 shares of FGEN stock, worth $4,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,000

Previous 10,000 -0.0%

Holding current value

$4,000

Previous $8,000 50.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.89 - $2.36 $20,487 - $54,327	-23,020 Reduced 69.72%	10,000 $8,000
Q1 2024 May 10, 2024	SELL	$0.73 - $2.73 $908 - $3,398	-1,245 Reduced 3.63%	33,020 $77,000
Q4 2023 Feb 09, 2024	BUY	$0.38 - $0.91 $4,303 - $10,304	11,324 Added 49.36%	34,265 $30,000
Q3 2023 Nov 13, 2023	SELL	$0.79 - $2.83 $77,851 - $278,885	-98,546 Reduced 81.12%	22,941 $19,000
Q2 2023 Aug 15, 2023	BUY	$2.49 - $20.59 $77,267 - $638,928	31,031 Added 34.31%	121,487 $328,000
Q1 2023 May 12, 2023	BUY	$15.95 - $25.18 $1.05 Million - $1.67 Million	66,127 Added 271.8%	90,456 $1.69 Million
Q4 2022 Feb 13, 2023	BUY	$13.27 - $17.73 $268,558 - $358,819	20,238 Added 494.7%	24,329 $389,000
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $9,405 - $12,045	-825 Reduced 16.78%	4,091 $54,000
Q2 2022 Aug 12, 2022	SELL	$7.94 - $12.96 $338,918 - $553,197	-42,685 Reduced 89.67%	4,916 $51,000
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $321,306 - $448,813	-26,731 Reduced 35.96%	47,601 $572,000
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $191,271 - $296,442	-19,262 Reduced 20.58%	74,332 $1.05 Million
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $171,186 - $447,978	-16,816 Reduced 15.23%	93,594 $957,000
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $796,690 - $1.53 Million	-42,902 Reduced 27.98%	110,410 $2.94 Million
Q1 2021 May 13, 2021	SELL	$31.0 - $55.72 $91,729 - $164,875	-2,959 Reduced 1.89%	153,312 $5.32 Million
Q4 2020 Feb 09, 2021	SELL	$37.09 - $48.97 $563,322 - $743,756	-15,188 Reduced 8.86%	156,271 $5.8 Million
Q3 2020 Nov 05, 2020	BUY	$40.47 - $45.5 $612,108 - $688,187	15,125 Added 9.67%	171,459 $7.05 Million
Q2 2020 Aug 13, 2020	BUY	$32.57 - $42.83 $701,199 - $922,087	21,529 Added 15.97%	156,334 $6.34 Million
Q1 2020 May 14, 2020	BUY	$23.3 - $45.96 $3.14 Million - $6.2 Million	134,805 New	134,805 $4.69 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $37.5M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Fibrogen Inc Transaction History